A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks


Gallbladder cancer (GBC) is the most common type of cancer with the worst prognosis among the bile duct cancers. There still remains a clear need for effective mechanism-based novel therapeutic approaches. A crosstalk between mitogen-activated protein kinase (MAPK) and the mammalian target of Rapamycin (mTOR) signaling pathways has been reported in several… (More)
DOI: 10.1007/s00535-015-1145-1

7 Figures and Tables


  • Presentations referencing similar topics